Article
High sensitivity of both sequencing and real-time PCR analysis of KRAS mutations in colorectal cancer tissue.
Journal of cellular and molecular medicine - 1 Aug 2010
Tol Jolien, Dijkstra Jeroen R, Vink-Börger Marianne E, Nagtegaal Iris D, Punt Cornelis J A, Van Krieken Johan H J M, Ligtenberg Marjolijn J L
Abstract excerpt
The KRAS mutation status predicts the outcome of treatment with epidermal growth factor receptor targeted agents, and therefore the testing for KRAS mutations has become an important diagnostic procedure. To optimize the quality of this test, we compared the results of the two most commonly used KRAS mutation tests, cycle sequencing and a real-time PCR-based assay, in DNA extracted from formalin-fixed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
